Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

AxyS advances development of APC-2059 for two different indications

Jan. 15, 2001

Nonpeptide caspase inhibitor holds promise for patients with fulminant hepatic failure

Jan. 15, 2001

Phase III compound for liver diseases licensed by Interneuron

Jan. 12, 2001

FDA clearance sought to begin clinical trials of levovirin

Jan. 11, 2001

IMP dehydrogenase inhibitors potentiate anti-HBV activity of nucleoside analogues

Jan. 11, 2001

Prospective trial compares efficacy of teprenone and rabeprazole against NSAID-induced GI lesions

Jan. 10, 2001

New series of sphingomyelinase inhibitors described by Ono researchers

Jan. 8, 2001

Pregabalin may have beneficial effects in the treatment of abdominal pain

Jan. 3, 2001

Global rights for novel Japanese antiviral agent granted to Lilly

Jan. 2, 2001

Elan/Incara partnership plans immediate entry into pivotal IBD trials for OP-2000

Jan. 2, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...